» Articles » PMID: 9660254

Application of a New Method for Analysis of Exhaled Gas in Critically Ill Patients

Overview
Specialty Critical Care
Date 1998 Jul 11
PMID 9660254
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Application of a new method for analysis of exhaled gas in critically ill patients.

Design: Open study.

Setting: Surgical intensive care unit of an university hospital.

Patients: Thirty-seven consecutive, critically ill, mechanically ventilated patients.

Interventions: None.

Measurements And Results: Chemical analysis of the patient's exhaled gas was based upon substance adsorption and concentration onto activated charcoal, microwave desorption and gas chromatographic separation. Patients with acute respiratory distress syndrome (ARDS) exhaled less isoprene than those without ARDS [9.8 (8.2-21.6) vs 21.8 (13.9-41.4) nmol/m2 per min [median (95% confidence interval)], p = 0.04]. In patients who developed pulmonary infection, pentane elimination increased from 0.4 (0.0-5.4) to 2.7 (0.6-6.1, p = 0.05) nmol/m2 per min and isoprene elimination decreased from 5.2 (0-33) to 5.0 (0-17, p = 0.05) nmol/m2 per min, resulting in a significant increase in pentane/isoprene ratio from 0.1 (0-0.3) to 0.4 (0-15, p = 0.007) when compared to patients without pulmonary infection.

Conclusions: The new method allows quantitative analysis of human gas samples with low substance concentrations and is well suited for clinical studies which involve the investigation of metabolic processes in the lung and the body.

Citing Articles

Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.

Ji X, Ji H Am J Physiol Lung Cell Mol Physiol. 2024; 326(5):L596-L603.

PMID: 38469648 PMC: 11380973. DOI: 10.1152/ajplung.00266.2023.


Octane in exhaled breath to diagnose acute respiratory distress syndrome in invasively ventilated intensive care unit patients.

Hagens L, Heijnen N, Smit M, Verschueren A, Nijsen T, Geven I ERJ Open Res. 2023; 9(5).

PMID: 37850212 PMC: 10577595. DOI: 10.1183/23120541.00214-2023.


Acute Respiratory Distress Syndrome; A Review of Recent Updates and a Glance into the Future.

Ramji H, Hafiz M, Hammad Altaq H, Hussain S, Chaudry F Diagnostics (Basel). 2023; 13(9).

PMID: 37174920 PMC: 10177247. DOI: 10.3390/diagnostics13091528.


Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.

Sharma R, Zang W, Tabartehfarahani A, Lam A, Huang X, Devi Sivakumar A JAMA Netw Open. 2023; 6(2):e230982.

PMID: 36853606 PMC: 9975913. DOI: 10.1001/jamanetworkopen.2023.0982.


Smelling the Disease: Diagnostic Potential of Breath Analysis.

Sharma A, Kumar R, Varadwaj P Mol Diagn Ther. 2023; 27(3):321-347.

PMID: 36729362 PMC: 9893210. DOI: 10.1007/s40291-023-00640-7.